Wei Deng

11PUBLICATIONS
8CO-AUTHORS
Molecular targetsPharmacogenomicsCardiology (incl. cardiovascular diseases)Cancer cell biologyChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 09, 2025
Downregulation of Alox5 Inhibits Ferroptosis to Improve Doxorubicin-Induced Cardiotoxicity via the P53/SLC7A11 Pathway.

Wenxi Fang, Zhefu Hu, Bo Shen

|Feb 10, 2025
Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice.

Mengya Chen, Nan Zhao, Wenke Shi

|Jan 08, 2025
Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies.

Heng Zhang, Saiyang Xie, Wei Deng

|Oct 17, 2023
Epicardial Adipose Tissue: a Potential Therapeutic Target for Cardiovascular Diseases.

Wenxi Fang, Saiyang Xie, Wei Deng

|Mar 15, 2023
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications.

Saiyang Xie, Si-Chi Xu, Wei Deng

|May 31, 2021
Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1".

Hai-Han Liao, Jin-Xiu Zhu, Hong Feng

Pageof 2

Frequent Collaborators

6 joint publications

Tang Qizhu

1 joint publications

Heng Zhou

1 joint publications

Qing-Qing Wu

1 joint publications

Qing-Qing Wu